Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Dawn Christine Maroney Sells 30,000 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $10.77, for a total transaction of $323,100.00. Following the completion of the transaction, the insider now owns 1,726,097 shares in the company, valued at $18,590,064.69. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, August 22nd, Dawn Christine Maroney sold 7,074 shares of Alignment Healthcare stock. The shares were sold at an average price of $9.02, for a total transaction of $63,807.48.
• On Thursday, August 15th, Dawn Christine Maroney sold 20,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $8.70, for a total transaction of $174,000.00.
• On Friday, July 19th, Dawn Christine Maroney sold 36,700 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.01, for a total transaction of $367,367.00.

Alignment Healthcare Price Performance

NASDAQ:ALHC opened at $10.88 on Friday. The company has a 50-day moving average of $10.28 and a 200-day moving average of $8.33. The company has a market capitalization of $2.08 billion, a price-to-earnings ratio of -12.95 and a beta of 1.47. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $12.36. The company has a debt-to-equity ratio of 1.70, a quick ratio of 1.61 and a current ratio of 1.61.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Thursday, August 1st. The company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.01. The company had revenue of $681.29 million during the quarter, compared to the consensus estimate of $637.66 million. Alignment Healthcare had a negative net margin of 6.85% and a negative return on equity of 101.10%. The firm’s revenue for the quarter was up 47.3% compared to the same quarter last year. During the same period last year, the firm earned ($0.15) EPS. As a group, equities research analysts anticipate that Alignment Healthcare, Inc. will post -0.67 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Alignment Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in ALHC. Jacobs Levy Equity Management Inc. bought a new position in Alignment Healthcare during the 1st quarter valued at about $918,000. Vanguard Group Inc. raised its stake in shares of Alignment Healthcare by 1.0% in the first quarter. Vanguard Group Inc. now owns 9,239,472 shares of the company’s stock worth $45,828,000 after acquiring an additional 93,262 shares during the last quarter. Deerfield Management Company L.P. Series C grew its position in shares of Alignment Healthcare by 31.8% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company’s stock worth $85,250,000 after buying an additional 2,630,788 shares during the period. Bank of New York Mellon Corp grew its position in shares of Alignment Healthcare by 27.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 382,462 shares of the company’s stock worth $2,991,000 after buying an additional 82,559 shares during the period. Finally, Principal Financial Group Inc. acquired a new stake in shares of Alignment Healthcare during the 1st quarter worth approximately $57,000. 86.19% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Robert W. Baird raised their target price on shares of Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a research note on Wednesday, August 14th. Barclays raised their price target on shares of Alignment Healthcare from $4.50 to $7.00 and gave the stock an “underweight” rating in a research report on Monday, August 5th. Piper Sandler restated an “overweight” rating and issued a $10.00 price target (up from $8.00) on shares of Alignment Healthcare in a research report on Tuesday, August 6th. KeyCorp assumed coverage on shares of Alignment Healthcare in a research report on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, TD Cowen raised their price target on shares of Alignment Healthcare from $8.00 to $10.00 and gave the stock a “buy” rating in a research report on Tuesday, August 6th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $9.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.